Market intelligence for competitive advantage to the world's leading and emerging medtech companies.

Reports | Medtech Startups | Fundings

Global Market For Medical Device Technologies in Spine Surgery, 2014-2021
Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World

· Report #M540 · 384 Pages · 130 Exhibits · 38 Company Profiles
Published August 2015
*** Excerpts available upon request ***

Price: $2,450 (print or PDF; add $200 for both).
Site/Global License also available.

Order online or fax/email us your order form.

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes the diseases and disorders of the spine, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in spine surgery. The report provides a current and forecast to 2021 by region/country of procedures and manufacturer revenues for, specifically, Americas (United States, Rest of North America, Latin America), European Union (United Kingdom, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Rest of Asia/Pacific) and Rest of World. The forecast addresses the product- and country-specific impacts in the market of new technologies through the coming decade. The report profiles 38 of the most notable current and emerging companies in this industry, providing status and forecast data on their current products, current market position, and products under development.

Table of Contents
EXECUTIVE SUMMARY

SECTiON 1:       INTRODUCTION TO THE SPINAL COLUMN, SPINAL INJURIES AND DISORDERS
1.1      The Spinal Column and Associated Structures
1.1.1       Cervical Vertebrae (C1 – C7)
1.1.2       Thoracic Vertebrae (T1 – T12)
1.1.3       Lumbar Vertebrae (L1 – L5)
1.1.4       Sacral Spine
1.1.5       Intervertebral Discs
1.1.6       Purpose of the Vertebrae
1.1.7       The Nerve Structure of the Spine
1.1.7.1       The Central Nervous System (CNS)
1.1.7.2       The Peripheral Nervous System (PNS)
1.1.8       Other Spinal Cord and Nerve Structures
1.1.8.1       Cerebrospinal Fluid (CSF)
1.1.8.2       Meninges
1.1.8.3       Dermatomes
1.1.8.4       Bone Physiology and the Process of Healing
1.2      Spinal Disorders
1.2.1       Degenerative Disorders
1.2.1.1       Degenerative Disc Disease (DDD)
1.2.1.2       Herniated Disc
1.2.1.3       Spinal Stenosis
1.2.1.4       Spondylosis
1.2.1.5       Spondylolisthesis
1.2.1.6       Osteoporosis
1.2.1.7       Rheumatoid Arthritis
1.2.1.8       Paget’s Disease
1.2.1.9       Spinal Trauma
1.2.1.10     Spinal Deformities
1.2.1.11     Spinal Tumors

SECTION 2:        SURGICAL PROCEDURES FOR SPINAL INJURIES AND DISORDERS

2.1      Introduction

2.2      Anterior Lumbar Interbody Fusion (ALIF)

2.3      Anterior Cervical Corpectomy

2.4      Anterior Cervical Discectomy and Fusion (ACDF)

2.5      Axial Lumbar Interbody Fusion (AXiaLIF)

2.6      Cervical Laminaplasty

2.7      Cervical Posterior Foraminotomy

2.8      Direct Lateral Interbody Fusion (DLIF)

2.9      Discectomy

2.10   Endoscopic Surgery

2.11   eXtreme Lateral Interbody Fusion (XLIF)

2.12   Foraminotomy and Foraminectomy

2.13   Intradiscal Electrothermal Therapy (IDET)

2.14   Kyphoplasty

2.15   Laminectomy

2.16   Laminoplasty

2.17   Laminotomy

2.18   LASER Surgery

2.19   Microdiscectomy (Minimally Invasive Technique)

2.20   Oblique Lumbar Interbody Fusion (PLIF)

2.21   Posterior Lumbar Interbody Fusion (PLIF)

2.22   Scoliosis Correction

2.23   Spinal Decompression

2.24   Spinal Fusion

2.25   Spinal Instrumentation

2.26   Spinal Osteotomy

2.27   Thoracoscopic Release

2.28   Transforamenal Lumbar Interbody Fusion (TLIF)

SECTION 3:        CURRENT PRODUCT AND TECHNOLOGY REVIEW, EMERGING TECHNOLOGIES AND LATEST DEVELOPMENTS
3.1      Introduction
3.2      Current Product Segments
3.2.1       Cervical Implants
3.2.1.1       Background and Market Segmentation
3.2.1.2       Selected Cervical Implants and Technologies
3.2.2       Thoracolumbar Implant Devices
3.2.2.1       Background and Market Segmentation
3.2.3       Minimally Invasive Implants and Surgery
3.2.4       Non Fusion Implants
3.2.4.1       Artificial Disc Replacement Implants
3.2.4.2       Interspinous Implants
3.2.5       Orthobiologics
3.2.5.1       Demineralised Bone Matrix (DBM)
3.2.5.2       Synthetic Bone Graft Substitutes

SECTION 4:        SUMMARY GLOBAL MARKET FOR MEDICAL DEVICES USED TO TREAT SPINAL DISORDERS
4.1      Introduction
4.2      Market Revenue Analysis
4.2.1       Global: Market Revenue Analysis
4.2.2       Global Market Revenue Analysis by Individual Region
4.2.3       Global Market Revenue Analysis by Individual Market Segments
4.3      Market Share Analysis
4.3.1       Global Market Share Analysis
4.3.2       Market Share Analysis by Selected Market Segment

SECTION 5:        THE NORTH AMERICAN MARKET: REVIEW AND ANALYSIS
5.1      Introduction
5.2      Regulatory and Legislative requirements
5.2.1       United States
5.2.1.1       Medical Devices Regulations (FDA)
5.2.1.2       FDA Classification of Spinal Systems
5.2.1.3       Centers for Medicare & Medicaid Services (CMS)
5.2.1.4       The 2010 Affordable Care Act
5.2.1.5       Private Insurance
5.2.1.6       Summary of Health Insurance Coverage in the United States
5.2.1.1       The Reimbursement Process United States
5.2.2       Canada
5.3      Market Dynamics
5.3.1       Market Drivers
5.3.1.1       Increased Rates of Spinal Fusions in the United States
5.3.1.2       Significant Advances in Implant Design and Materials Helps Stimulate Market Development
5.3.1.3       Continued Growth and Development of Minimally Invasive Spinal Fusion
5.3.2       Market Restraints
5.3.2.1       Cost Containment Issues Restrain Growth and Development of the Implant Industry
5.3.2.2       Reimbursement Coverage Crisis for Minimally Invasive Spinal Surgery in the United States
5.3.2.3       Spinal Fusion Cost and Imbursement Issues (Impact of The Affordable Care Act and Increased Scrutiny by the Centers for Medicare & Medicaid Services (CMS)
5.3.2.4       Medicare MACs and RACs finding high error rates with spinal fusion DRG-460
5.3.2.5       Increased Transparency of Spine Reimbursement Numbers Highlights Discrepancies Across Hospitals
5.3.3       Anticipated Key Market Development in the Spinal Fusion Market in the United States
5.4      Market Revenue Analysis
5.4.1       North America: Market Revenue Analysis (Spinal Fusion)
5.4.2       North America: Market Revenue Analysis by Market Segment
5.4.2.1       North America: Market Revenue Analysis (Cervical Fusion)
5.4.2.2       North America: Market Revenue Analysis (Thoracolumbar Fusion)
5.4.2.3       North America: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
5.4.2.4       North America: Market Revenue Analysis (Interbody Fusion Devices)
5.4.2.5       North America: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
5.4.3       North America: Market Revenue Analysis by Selected Individual Country
5.5      North America: Market Share Analysis
5.5.1       North America: Market Share Analysis by Individual Market Segments

SECTION 6:        THE EUROPEAN MARKET REVIEW AND ANALYSIS
6.1      Introduction
6.2      Regulatory and Legislative requirements
6.2.1       General) Medical Device Directive, MDD (93/42/EEC)
6.2.2       Active Implantable Medical Device Directive, AIMDD (90/385/EEC)
6.2.3       In Vitro Diagnostic Medical Device Directive, IVDMDD (98/79/EC)
6.2.4       Proposal for Changes to the Medical Device Directive, MDD (93/42/EEC)
6.2.5       Notified Bodies
6.2.6       Medical Devices Legislation and Regulations: The Russian Federation
6.3      Market Dynamics
6.3.1       Market Drivers
6.3.1.1       Technological Advances in Product Design and Material Innovations Help Stimulate the Market
6.3.1.2       Increased Incidence of Degenerative Disease of the Lower Back Market
6.3.1.3       Creation of Lucrative Private Healthcare Spinal Fusions Market
6.3.1.4       Emergence of Minimally Invasive Spinal Surgery
6.3.2       Market Restraints
6.3.2.1       Cost Containment and Reimbursement Issues Significantly Affect Market Growth for Spinal Implants
6.3.2.2       Concerns over the Appropriate Use of Pedicular Screw Fixation
6.3.2.3       Increased Competitive Activity and Competitive Product Pricing Regarded as a Major Market Restraint
6.4      Market Revenue Analysis
6.4.1       Europe: Market Revenue Analysis (Spinal Fusion)
6.4.2       Europe: Market Revenue Analysis by Market Segment
6.4.2.1       Europe: Market Revenue Analysis (Cervical Fusion)
6.4.2.2       Europe: Market Revenue Analysis (Thoracolumbar Fusion)
6.4.2.3       Europe: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
6.4.2.4       Europe: Market Revenue Analysis (Interbody Fusion Devices)
6.4.2.5       Europe: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
6.4.3       Europe: Market Revenue Analysis by Selected Individual Country
6.5      Europe: Market Share Analysis
6.5.1       Europe: Market Share Analysis by Individual Market Segments

SECTION 7:        THE ASIA/PACIFIC MARKET REVIEW AND ANALYSIS
7.1      Introduction
7.1.1       Japan
7.1.1.1       Regulatory and Legislative Requirements
7.1.1.2       Marketing Authorization System
7.1.2       China
7.1.2.1       Overview of the Healthcare System
7.1.2.2       Healthcare Reforms
7.1.3       India
7.1.3.1       Overview of the Healthcare System
7.1.4       South Korea
7.2      Market Dynamics
7.2.1       Market Drivers
7.2.1.1       Growth and Development of Spinal Fusion Market in the Booming Economies in Emerging Markets
7.2.1.2       Growth and Development of the Chinese Market
7.2.1.3       Growth and Development of the Indian Market
7.2.2       Market Restraints
7.2.2.1       China
7.2.2.2       India
7.2.2.3       Japan
7.3      Market Revenue Analysis
7.3.1       Asia Pacific: Market Revenue Analysis
7.3.2       Asia Pacific: Market Revenue Analysis by Market Segment
7.3.2.1       Asia Pacific: Market Revenue Analysis (Cervical Fusion)
7.3.2.2       Asia Pacific: Market Revenue Analysis (Thoracolumbar Fusion)
7.3.2.3       Asia Pacific: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
7.3.2.4       Asia Pacific: Market Revenue Analysis (Interbody Fusion Devices)
7.3.2.5       Asia Pacific: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
7.3.3       Asia Pacific: Market Revenue Analysis by Selected Individual Country
7.4      Asia Pacific: Market Share Analysis
7.4.1       Asia Pacific: Market Share Analysis by Individual Market Segments

SECTION 8:        THE REST OF THE WORLD MARKET: REVIEW AND ANALYSIS

8.1      Introduction
8.2      Brazil
8.2.1       Background
8.2.2       Regulatory and Legislative Requirements
8.2.3       Market Entry and Reimbursement of Medical Devices: Brazil
8.3      Argentina
8.3.1       Background
8.3.2       Government-funded Public Health Sector
8.3.3       Social Health Insurance Sector
8.3.4       Private sector
8.3.5       Regulatory and Legislative Requirements
8.4      Mexico
8.4.1       Legislation and Regulations Governing Medical Devices in Mexico
8.4.2       Health Insurance Structure Mexico
8.5      Market Dynamics
8.5.1       Market Drivers
8.5.1.1       Significant Market growth Opportunities in Brazil
8.5.1.2       Brazilian Government Incentives Favor Local Development and Production
8.5.1.3       Expansion of Healthcare Opportunities in Mexico
8.5.1.4       Introduction of Tax Funded Universal Health Coverage Throughout Latin America
8.5.1.5       Aging Populations in Central and Latin America Set to Increase Burden of Low Back Pain
8.5.2       Market Restraints
8.5.2.1       Diverse Regulatory Environment Constrains Latin American Medical Device Market
8.5.2.2       Challenges Associated with Local Business Practices and Cultural Conditions in Brazil
8.5.2.3       Issues Associated with the Distribution of Medical Devices in Latin America
8.5.2.4       Pricing Issues
8.5.2.5       Increased Use and Reliance on Health Technology Assessments (HTAs), Tenders and Fixed Reimbursement Rates
8.5.2.6       Importance of Local Companies Presence in Caribbean and Central and Latin American Countries
8.6      Market Revenue Analysis
8.6.1       Central and Latin America: Market Revenue Analysis
8.6.2       Central and Latin America: Market Revenue Analysis by Market Segment
8.6.2.1       Central and Latin America: Market Revenue Analysis (Cervical Fusion)
8.6.2.2       Central and Latin America: Market Revenue Analysis (Thoracolumbar Fusion)
8.6.2.3       Central and Latin America: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
8.6.2.4       Central and Latin America: Market Revenue Analysis (Interbody Fusion Devices)
8.6.2.5       Central and Latin America: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
8.6.3       Central and Latin America: Market Revenue Analysis by Selected Individual Country
8.6.4       Central and Latin America: Market Share Analysis
8.6.4.1       Central and Latin America: Market Share Analysis by Individual Market Segments

SECTION 9:        COMPANY PROFILES
9.1      Accel Spine
9.2      Alliance Spine
9.3      Alphatec Spine
9.4      Amedica
9.5      Aesculap AG & Co AG a division of B. Braun Mesungen AG
9.6      Apollo Spine
9.7      A.W.M. Art World Medical
9.8      Baumer S.A.
9.9      Bonovo Orthopedic, Inc
9.10   Centinel Spine
9.11   coLigne AG
9.12   Depuy Synthes(Johnson & Johnson)
9.13   Dieter Marquardt Medizintechnik GmbH
9.14   Exactech
9.15   Globus Medical
9.16   Integra Lifesciences (Sea Spine)
9.17   Japan Medical Dynamic Marketing, Inc. (Japan MDM)
9.18   K2M
9.19   KYOCERA Medical Corporation
9.20   LDR Holding Corporation
9.21   Medicrea International
9.22   Medtronic
9.23   NuVasive
9.24   Precision Spine
9.25   SI-BONE
9.26   Spineart
9.27   SpineGuard
9.28   Spine Surgical Innovations
9.29   Spine Wave
9.30   Stryker Inc
9.31   Titan Spine
9.32   TranS1
9.33   Wright Medical Group, Inc. (Wright Medical Technology Inc.)
9.34   Ulrich Medical
9.35   Wenzel Spine
9.36   X-spine
9.37   Zimmer Biomet Holdings, Inc
9.38   Zyga Technology

APPENDICES
Appendix 1: Company Addresses and Contact Details

Appendix 2: Glossary of Terminology

List of Exhibits

 

Exhibit ES-1: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit ES-2: Global Spine Market Forecast: Medical Device Technologies Used for Spinal Fusion by Region 2014

Exhibit ES-3: Global Spine Market Forecast, Medical Device Technologies Used for Spinal Fusion ($ millions) by Individual Segment 2014

Exhibit ES-4: Global Spine Market Forecast: Medical Device Technologies Used for Spinal Fusion ($ millions) by Individual Segment 2014

Exhibit ES-5: Global Market Share Analysis: Medical Device Technologies Used for Spinal Fusion 2014

 

Exhibit 1-1: Structure of the Vertebral Column

Exhibit 1-2: Structure of the Vertebral Column

Exhibit 1-3: Structure of the Cervical Vertebrae

Exhibit 1-4: Structure of the Thoracic Vertebrae

Exhibit 1-5: Structure of the Lumbar Vertebrae

Exhibit 1-6: Relationship between Intervertebral Disc and Vertebrae

Exhibit 1-7: Structure of the Intervertebral Disc

Exhibit 1-8: Functions of the Vertebral Column

Exhibit 1-9: Schematic Diagram of Relationship between the CNS and PNS

Exhibit 1-10: Spinal Nerves

Exhibit 1-11: Principle Structure and Relationship between Vertebrae and Spinal Nerves

Exhibit 1-12: Summary of the Normal Bone Remodeling-Normal Maintenance and Repair Process

Exhibit 1-13: Degenerative Spinal Disorders

Exhibit 1-14: Stages of Disc Herniation

Exhibit 1-15: Spinal Stenosis

Exhibit 1-16: Spinal Stenosis

Exhibit 1-17: Diagram of the Different Types of Scolosis

Exhibit 1-18: Diagram of Kyphosis

Exhibit 1-19: Diagram of Lordosis

 

Exhibit 3-1: Classification of Anterior Cervical Plates 6-

Exhibit 3-2: Constrained Rotational versus Constrained Translational Anterior Cervical Plates (ACPs)

 

Exhibit 4-1: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-2: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-3: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2014

Exhibit 4-4: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2021

Exhibit 4-5: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2011 - 2021

Exhibit 4-6: North America: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-7: Europe: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-8: Asia Pacific: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-9: Central and Latin America: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-10: Global Market: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) By individual Segment 2014

Exhibit 4-11: Global Market: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) By individual Segment 2014

Exhibit 4-12: Global Market: Revenue Forecasts, Cervical Fusion ($ millions) 2011 - 2021

Exhibit 4-13: Global Market: Revenue Forecasts, Cervical Fusion ($ millions) by Geographic Region 2014

Exhibit 4-14: Global Market: Revenue Forecasts, Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 4-15: Global Market: Revenue Forecasts, Thoracolumbar Implants ($ millions) by Geographic Region 2014

Exhibit 4-16: Global Market: Revenue Forecasts, Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-17: Global Market: Revenue Forecasts, Minimally Invasive Spinal Fusion ($ millions) by Geographic Region 2014

Exhibit 4-18: Global Market: Revenue Forecasts, Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 4-19: Global Market: Revenue Forecasts, Interbody Fusion Devices ($ millions) by Geographic Region 2014

Exhibit 4-20: Global Market: Revenue Forecasts, Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 4-21: Global Market: Revenue Forecasts, Orthobiologics for Spinal Fusion ($ millions) by Geographic Region 2014

Exhibit 4-22: Global Market Share Analysis, Medical Device Technologies Used For Spinal Fusion 2014

Exhibit 4-23: Global Market Share Analysis, Medical Device Technologies Used For Spinal Fusion 2014

Exhibit 4-24: Global Market Share Analysis, Cervical Fusion, 2014

Exhibit 4-25: Global Market Share Analysis, Thoracolumbar Implants, 2014

Exhibit 4-26: Global Market Share Analysis, Minimally Invasive Spinal Fusion, 2014

Exhibit 4-27: Global Market Share Analysis, Interbody Fusion Devices, 2014

Exhibit 4-28: Global Market Share Analysis, Orthobiologics for Spinal Fusion, 2014

 

Exhibit 5-1: Private health insurance coverage among persons under age 65: United States, 2007-2011

Exhibit 5-2: Personal Health Care Expenditures; Aggregate and per Capita Amounts, Percent Distribution and Annual Percent Change by Source of Funds: Calendar Years 2006-2018 ($ Billions)

Exhibit 5-4: Hospital Discharges for Select Spine Procedures as a Proportion of All Spine Procedures, United States 2007 and 2011

Exhibit 5-5: North America: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-6: North America: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-7: North America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 5-8: North America: Revenue Forecasts: Cervical Infusion ($ millions) 2011 - 2021

Exhibit 5-9: North America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 5-10: North America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 5-11: North America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-12: North America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-13: North America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 5-14: North America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 5-15: North America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-16: North America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 5-17: United States: Spine Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 5-18: United States: Revenue for Cervical, Thoracolumbar and MIS Fusion ($ millions) 2011 - 2021

Exhibit 5-19: United States: Revenue for Interbody Fusion and Spine Orthobiologics ($ millions) 2011 - 2021

Exhibit 5-20: North America, Market Share Analysis Medical Device Technologies Used For Spinal Fusion (2014)

Exhibit 5-21: North America Market Share Analysis, Cervical Fusion, 2014

Exhibit 5-22: North America Market Share Analysis, Thoracolumbar Implants, 2014

Exhibit 5-23: North America Market Share Analysis, Minimally Invasive Spinal Fusion, 2014

Exhibit 5-24: North America Market Share Analysis, Interbody Fusion Devices, 2014

Exhibit 5-25: North America Market Share Analysis, Orthobiologics for Spinal Fusion, 2014

 

Exhibit 6-1: Europe: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021

Exhibit 6-2: Europe: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021

Exhibit 6-3: Europe: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 6-4: Europe: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 6-5: Europe: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 6-6: Europe: Revenue Forecasts: Thoracolumbar Implants ($ billions) 2011 - 2021

Exhibit 6-7: Europe: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 6-8: Europe: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 6-9: Europe: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 6-10: Europe: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 6-11: Europe: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 6-12: Europe: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 6-13: Germany: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-14: France: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-15: Italy: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-16: Spain: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-17: United Kingdom: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-18: Benelux: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-19: Scandinavia: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-20: Rest of Europe: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 6-21: Europe, Market Share Analysis, Spinal Implants and Associated Spinal Fusion Products (2014)

Exhibit 6-22: Europe Market Share Analysis, Cervical Fusion, 2014

Exhibit 6-23: Europe Market Share Analysis, Thoracolumbar Implants, 2014

Exhibit 6-24: Europe Market Share Analysis, Minimally Invasive Spinal Fusion, 2014

Exhibit 6-25: Europe Market Share Analysis, Interbody Fusion Devices, 2014

Exhibit 6-26: Europe Market Share Analysis, Orthobiologics for Spinal Fusion, 2014

 

Exhibit 7-1: Overview of Pharmaceutical Affairs Law (PAL) and Japanese Medical Devices Nomenclature (JMDN) codes and related codes according to the EU MDD

Exhibit 7-2: Reimbursement Categories: Japan

Exhibit 7-3: The Chinese Healthcare System

Exhibit 7-4: Number of Healthcare Institutions According to Ownership China, 2010

Exhibit 7-5: Total Number of Hospitals by Ranking China, 2010

Exhibit 7-6: Overview of Healthcare in India

Exhibit 7-7: Asia Pacific: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 7-8: Asia Pacific: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021

Exhibit 7-9: Asia Pacific: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 7-10: Asia Pacific: Revenue Forecasts: Cervical Infusion ($ millions) 2011 - 2021

Exhibit 7-11: Asia Pacific: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 7-12: Asia Pacific: Revenue Forecasts: Thoracolumbar Implants ($ billions) 2011 - 2021

Exhibit 7-13: Asia Pacific: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 7-14: Asia Pacific: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ billions) 2011 - 2021

Exhibit 7-15: Asia Pacific: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 7-16: Asia Pacific: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 7-17: Asia Pacific: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 7-18: Asia Pacific: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ billions) 2011 - 2021

Exhibit 7-19: China: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 7-20: India: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 7-21: Japan: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 7-22: Asia Pacific, Market Share Analysis, Medical Device Technologies Used For Spinal Fusion (2014)

Exhibit 7-23: Asia Pacific, Market Share Analysis, Cervical Fusion, 2014

Exhibit 7-24: Asia Pacific, Market Share Analysis, Thoracolumbar Implants, 2014

Exhibit 7-25: Asia Pacific, Market Share Analysis, Minimally Invasive Spinal Fusion, 2014

Exhibit 7-26: Asia Pacific, Market Share Analysis, Interbody Fusion Devices, 2014

Exhibit 7-27: Asia Pacific, Market Share Analysis, Orthobiologics for Spinal Fusion, 2014

 

Exhibit 8-1: Central and Latin America: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021

Exhibit 8-2: Central and Latin America: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021

Exhibit 8-3: Central and Latin America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 8-4: Central and Latin America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021

Exhibit 8-5: Central and Latin America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 8-6: Central and Latin America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021

Exhibit 8-7: Central and Latin America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 8-8: Central and Latin America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021

Exhibit 8-9: Central and Latin America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 8-10: Central and Latin America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021

Exhibit 8-11: Central and Latin America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 8-12: Central and Latin America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021

Exhibit 8-13: Argentina: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 8-14: Brazil: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 8-15: Mexico: Revenue Analysis: ($ millions) 2011 - 2021

Exhibit 8-16: Central and Latin America, Market Share Analysis, Spinal Implants and Associated Spinal Fusion Products (2014)

Exhibit 8-17: Central and Latin America Market Share Analysis, Cervical Fusion, 2014

Exhibit 8-18: Central and Latin America Market Share Analysis, Thoracolumbar Implants, 2014

Exhibit 8-19: Central and Latin America Market Share Analysis, Minimally Invasive Spinal Fusion, 2014

Exhibit 8-20: Central and Latin America Market Share Analysis, Interbody Fusion Devices, 2014

Exhibit 8-21: Central and Latin America Market Share Analysis, Orthobiologics for Spinal Fusion, 2014

 


Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.


 

Report #M540

Global Market For Medical Device Technologies in Spine Surgery, 2014-2021. Published August 2015.
   · 380 pages   · 130 Exhibits   · 38 Company Profiles  

 

Price: $3,850 for print or PDF; add $200 to receive for both

Order online or fax/email us your order form.  Site/Global License also available.


Order Reports online for instant download.
See Online Store or any "order online" link.
Credit Card Processing

Reports library access is also available through annual contract.


Medtech Startups Database

MedMarket Diligence offers the Medtech Startups Database.
A unique source of detail on new medical technology companies

About the Medtech Startups Database.